Role of phytic acid in cancer and other diseases

Food Phytates

Volumn , Issue , 2001, Pages 225-248

  Jenab, Mazda ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056560546     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (131)

1. Reddy, N.R., Sathe, S., and Salunkhe, D.K. 1982. Phytates in legumes and cereals. Adv. Food Res. 28:1-92.
2. Graf, E. and Eaton, J.W. 1984. Effects of phytate on mineral bioavailability in mice. J. Nutr. 114:1192-1198.
3. Graf, E., Empson, K.L., and Eaton, J.W. 1987. Phytic acid: a natural antioxidant. J. Biol. Chem. 262:11647-11650.
4. Rickard, S.E. and Thompson, L.U. 1997. Interactions and biological effects of phytic acid, in Antinutrients and Phytochemicals in Food, Shahidi, F., Ed., American Chemical Society, Washington, D.C., pp. 294-312.
5. Cheryan, M. 1980. Phytic acid interactions in food systems. Crit. Rev. Food Sci. Nutr. 13:297-335.
6. Brune, M., Rossander, L., and Hallberg, L. 1989. Iron absorption: no intestinal adaptation to a high-phytate diet. Am. J. Clin. Nutr. 49:542-545.
7. Torre, M., Rodriguez, A.R., and Saura-Calixto, F. 1991. Effects of dietary fiber and phytic acid on mineral bioavailability. Crit. Rev. Food. Sci. Nutr. 1:1-22.
8. Zhou, J.R. and Erdman, J.W. 1995. Phytic acid in health and disease. Crit. Rev. Food Sci. Nutr. 35:495-508.
9. Morris, E.R. and Ellis, R. 1980. Bioavailability to rats of iron and zinc in wheat bran: response to low-phytate bran and effect of the phytate/zinc molar ratio. J. Nutr. 110:2000-2010.
10. Sathe, S.K. and Salunkhe, D.K. 1984. Technology of removal of unwanted components of dry beans. Crit. Rev. Food Sci. Nutr. 21:263-287.
11. Thompson, L.U. and Cho, Y.S. 1984. Effect of acylation upon extraction of nitrogen, minerals and phytic acid in rapeseed flour and protein concentrate. J. Food Sci. 49:771-774.
12. Thompson, L.U. 1995. Phytic acid and other nutrients: are they partly responsible for health benefits of high fiber foods, in Dietary Fiber in Health and Disease, Kritchevsky, D. and Bonfield, C., Eds., Egan Press, New York, pp. 305-317.
13. Nielsen, B.K., Thompson, L.U., and Bird, R.P. 1987. Effect of phytic acid on colonic epithelial cell proliferation. Cancer Lett. 37:317-325.
14. Shamsuddin, A.M., Elsayed, A.M., and Ullah, A. 1988. Suppression of large intestinal cancer in F-344 rats by inositol hexaphosphate. Carcinogenesis 9:577-583.
15. Thompson, L.U. and Zhang, L. 1991. Phytic acid and minerals: effect on early markers of risk for mammary and colon carcinogenesis. Carcinogenesis 12:2041-2045.
16. Vucenik, I., Yang, G.Y., and Shamsuddin, A.M. 1997. Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr. Cancer 28:7-13.
17. Jenab, M. and Thompson, L.U. 1998. The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis 19:1087-1092.
18. Shamsuddin, A.M. 1995. Inositol phosphates have novel anticancer function. J. Nutr. 125:725S-732S.
19. Sakamoto, K., Venkatraman, G., and Shamsuddin, A.M. 1993. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). Carcinogenesis 14:1815-1819.
20. Yang, G.Y. and Shamsuddin, A.M. 1995. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Anticancer Res. 15:2479-2487.
21. Saied, I.T. and Shamsuddin, A.M. 1998. Up-regulation of the tumour suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res. 18:1479-1484.
22. Corpet, D.E., Tache, S., and Peiffer, G. 1997. Colon tumour promotion: is it a selection process? Effects of cholate, phytate and food restriction in rats on proliferation and apoptosis in normal and aberrant crypts. Cancer Lett. 114:135-138.
23. Shamsuddin, A.M., Ullah, A., and Chakravarthy, A. 1989. Inositol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 10:1461-1463.
24. Shamsuddin, A.M. and Ullah, A. 1989. Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 10:625-626.
25. Ullah, A. and Shamsuddin, A.M. 1990. Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Carcinogenesis 11:2219-2222.
26. Pretlow, T.P., O’Riordan, M.A., Somich, G.A., Amini, S.B., and Pretlow, T.G. 1992. Aberrant crypts correlate with tumour incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13:1509-1512.
27. Bird, R.P. 1995. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93:55-71.
28. Pretlow, T.P., Cheyer, C., and O’Riordan, M.A. 1994. Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity. Int. J. Cancer 56:599-602.
29. Jenab, M. and Thompson, L.U. 2001. Sialomucin production in aberrant crypt foci relates to degree of dysplasia and rate of cell proliferation. Cancer Lett. 165:19-25.
30. Stopera, S.A. and Bird, R.P. 1993. Immunohistochemical demonstration of mutant p53 tumor suppressor gene product in aberrant crypt foci. Cytobios. 73:73-88.
31. Stopera, S.A., Murphy, L.C., and Bird, R.P. 1992. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis 13:2081-2085.
32. Shivapurkar, N., Tang, Z.C., Frost, A., and Alabaster, O. 1996. A rapid dual organ rat carcinogenesis bioassay for evaluating the chemoprevention of breast and colon cancer. Cancer Lett. 100:169-179.
33. Nelson, R.L., Yoo, S.J., Tanure, G., Andrianopoulos, G., and Misumi, A 1989. The effect of iron on experimental colorectal carcinogenesis. Anticancer Res. 9:1477-1482.
34. Challa, A., Rao, D.R., and Reddy, B.S. 1997. Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea. Carcinogenesis 18:2023-2026.
35. Jenab, M. and Thompson, L.U. 2000. Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis. Carcinogenesis 21:1547-1552.
36. Graf, E. and Eaton, J.W. 1990. Antioxidant functions of phytic acid. Free Radical Biol. Med. 8:61-69.
37. Graf, E. and Eaton, J.W. 1993. Suppression of colonic cancer by dietary phytic acid. Nutr. Cancer 19:11-19.
38. Stevens, R.G., Beasely, R.P., and Blumberg, B.S. 1986. Iron binding proteins and risk of cancer in Taiwan. J. Nat. Cancer Inst. 76:605-610.
39. Stevens, R.G., Jones, D.Y., Micozzi, M.S., and Taylor, P.R. 1988. Body iron stores and the risk of cancer. N. Eng. J. Med. 319:1047-1052.
40. Selby, J.V. and Friedman, G.D. 1988. Epidemiologic evidence of an association between body iron stores and risk of cancer. Int. J. Cancer 41:677-682.
41. Wurzelmann, J.I., Silver, A., Schreinemachers, D.M, Sandler, R.S., and Everson, R.B. 1996. Iron intake and risk of colon cancer. Cancer Epidemiol. Biomark. Prev. 5:503-507.
42. Owen, R.W., Weisgerber, U.M., Spiegelhalder, B., and Bartsch, H. 1996. Faecal phytic acid and its relation to other putative markers of risk for colorectal cancer. Gut 38:591-597.
43. Risio, M., Lipkin, M., Candelaresi, G., Bertone, A., Coverlizza, S., and Rossini, F.P. 1991. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of non-familial neoplasia of the large intestine. Cancer Res. 51:1917-1921.
44. Vucenik, I., Yang, G.Y., and Shamsuddin, A.M. 1997. Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr. Cancer 28:7-13.
45. Reddy, B.S., Hirose, Y., Cohen, L.A., Simi, B., Cooma, I., and Rao, C.V. 2000. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Cancer Res. 60:4792-4797.
46. Shamsuddin, A.M. and Vucenik, I. 1999. Mammary tumor inhibition by IP6: a review. Anticancer Res. 19:3671-3674.
47. Wilson, R.B., Hutcheson, D.P., and Wideman, L. 1977. Dimethylhydrazine induced colon tumors in rats fed diets containing beef fat or corn oil with or without wheat bran. Amer. J. Clin. Nutr. 30:176-181.
48. Chen, W.F., Patchevsky, A.S., and Goldsmith, H.S. 1978. Colonic protection from dimethylhydrazine by a high fiber diet. Surg. Gyn. Obs. 147:503-506.
49. Reddy, B.S. and Mori, H. 1981. Effect of dietary wheat bran and dehydrated citrus fiber on 3,2-dimethyl-4-aminobiphenyl induced intestinal carcinogenesis in F344 rats. Carcinogenesis 2:21-25.
50. Barnes, D.S., Clapp, N.K., Scott, D.A., Oberst, D.L., and Berry, S.G. 1983. Effects of wheat, rice, corn and soybean bran on 1,2-dimethylhydrazine-induced large bowel tumourigenesis in F344 rats. Nutr. Cancer 5:1-9.
51. Maziya-Dixon, B.B., Klopfenstein, C.F., and Leipold, H.W. 1994. Protective effects of hard red wheat versus hard white wheats in chemically induced colon cancer in CF1 mice. Cereal Chem. 71:359-363.
52. Shamsuddin, A.M., Yang, G.Y., andVucenik, I. 1996.Novel anticancer function of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res. 16:3287-3292.
53. Vucenik, I., Sakamoto, K., Bansal, M., and Shamsuddin, A.M. 1993. Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study. Cancer Lett. 75:95-101.
54. Vucenik, I., Yang, G.Y., and Shamsuddin, A.M. 1995. Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis 16:1055-1058.
55. Hirose, M., Hoshiya, T., Akagi, K., Futakuchi, M., and Ito, N. 1994. Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[alpha]anthracene. Cancer Lett. 83:149-156.
56. Shamsuddin, A.M., Baten, A., and Lalwani, N.D. 1992. Effects of inositol hexaphosphate on growth and differentiation in K-562 erythroleukemia cell line. Cancer Lett. 64:195-202.
57. Shamsuddin, A.M. and Yang, G.Y. 1995. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis 16:1975-1979.
58. Vucenik, I., Tantivejkul, K., Zhang, Z.S., Cole, K.E., Saied, I., and Shamsuddin, A.M. 1998. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res. 18:4083-4090.
59. Vucenik, I., Kalebic, T., Tantivejkul, K., and Shamsuddin, A.M. 1998. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo. Anticancer Res. 18:1377-1384.
60. Vucenik, I., Zhang, Z.S., and Shamsuddin, A.M. 1998. IP6 in treatment of liver cancer. II. Intra-tumoural injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice. Anticancer Res. 18:4091-4096.
61. Jariwalla, R.J., Sabin, R., Lawson, S., Bloch, D.A., Prender, M., Andrews, V., and Herman, Z.S. 1988. Effect of dietary phytic acid (phytate) on the incidence and growth rate of tumors promoted in Fisher rats by magnesium supplement. Nutr. Res. 8:813-827.
62. Vucenik, I., Tomazic, V.J., Fabian, D., and Shamsuddin, A.M. 1992. Antitumour activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma. A pilot study. Cancer Lett. 65:9-13.
63. Ishikawa, T., Nakatsuru, Y., Zarkovic, M., and Shamsuddin, A.M. 1999. Inhibition of skin cancer by IP6 in vivo: initiation-promotion model. Anticancer Res. 19:3749-3752.
64. Hirose, M., Ozaki, K., Takaba, K., Fukushima, S., Shirai, T., and Ito, N. 1991. Modifying effects of the naturally occurring antioxidants gamma oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis 12:1917-1921.
65. Larsson, O., Barker, C.J., Sjoholm, A., Carlqvist, H., Michell, R.H., Bertorello, A., Nilsson, T., Honkanen, R.E., Mayr, G.W., Zwiler, J., and Berggren, P.O. 1997. Inhibition of phosphatases and increased Ca2+ channel activity by inositol hexakisphosphate. Science 278:471-474.
66. Vucenik, I. and Shamsuddin, A.M. 1994. [3H]Inositol Hexaphosphate (Phytic Acid) is rapidly absorbed and metabolized by murine and human malignant cells in vitro. J. Nutr. 124:861-868.
67. Sakamoto, K., Vucenik, I., and Shamsuddin, A.M. 1993. [3H]Phytic acid (inositol hexaphosphate) is absorbed and distributed to various tissues in rats. J. Nutr. 123:713-720.
68. Shears, S.B. 1998. The versatility of inositol phosphates as cellular signals. Biochim. Biophys. Acta 1436:49-67.
69. Singh, M. and Krikorian, A.D. 1982. Inhibition of trypsin activity in vitro by phytate. J. Agric. Food Chem. 30:799-800.
70. Thompson, L.U. 1986. Phytic acid: a factor influencing starch digestibility and blood glucose response, in Phytic Acid: Chemistry and Applications, Graf, E. Ed., Pilatus Press, Minneapolis, MN, pp. 173-194.
71. Gupta, M., Khetarpaul, N., and Chauhan, B.M. 1992. Rabadi fermentation of wheat: changes in phytic acid content and in vitro digestibility. Plant Foods Hum. Nutr. 42:109-116.
72. Yoon, J.H., Thompson, L.U., and Jenkins, D.J.A. 1983. The effect of phytic acid on in vitro rate of starch digestibility and blood glucose response. Amer. J. Clin. Nutr. 38:835-842.
73. Thompson, L.U., Button, C.L., and Jenkins, D.J.A. 1987. Phytic acid and calcium affect the in vitro rate of navy bean starch digestion and blood glucose response in humans. Am. J. Clin. Nutr. 46:467-473.
74. Coradini, D., Pellizzaro, C., Marimpietri, D., Abolafio, G., and Daidone, M.G. 2000. Sodium butyrate modulates cell cycle-related proteins in HT29 human colonic adenocarcinoma cells. Cell Prolif. 33:139-146.
75. Basson, M.D., Turowski, G.A., Rashid, Z., Hong, F., and Madri, J.A. 1996. Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Dig. Dis. Sci. 41: 1989-1993.
76. Hague, A., Manning, A.M., Hanlon, K.A., Huschtscha, L.I., Hart, D., and Paraskeva, C. 1993. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fiber in the prevention of large bowel cancer. Int. J. Cancer 55:498-505.
77. Caderni, G., Luceri, C., Lancioni, L., Tessitore, L., and Dolara, P. 1998. Slow-release pellets of sodium butyrate increase apoptosis in the colon of rats treated with azoxymethane, without affecting aberrant crypt foci and colonic proliferation. Nutr. Cancer 30:175-181.
78. McIntyre, A., Gibson, P.R., and Young, G.P. 1993. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34:386-391.
79. Newmark, H.L. and Lupton, J.R. 1990. Determinants and consequences of colonic luminal pH: implications for colon cancer. Nutr. Cancer 14:161-173.
80. Mallett, A.K., Bearne, C.A., and Rowland, I.R. 1989. The influence of incubation pH on the activity of rat and human gut flora enzymes. J. Appl. Bacteriol. 66:433-437.
81. Thornton, J.R. 1981. High colonic pH promotes colorectal cancer. Lancet 1:1081-1083.
82. Clinton, S.K., Dieterich, M., Bostwick, D.G., Olson, L.M., Montag, A.G., and Michelassi, F.1987. The effects of ammonia on N-methyl-N-nitrosoguanidine induced colon carcinogenesis and ras oncogene expression. FASEB J. 46:585-588.
83. Graf, E. and Eaton, J.W. 1990. Antioxidant functions of phytic acid. Free Radical Biol. Med. 8:61-69.
84. Nelson, R.L. 1992. Dietary iron and colorectal cancer risk. Free Rad. Bio. Med. 12:161-168.
85. Graf, E. and Eaton, J.W. 1993. Suppression of colonic cancer by dietary phytic acid. Nutr. Cancer 19:11-19.
86. Rimbach, G. and Pallauf, J. 1998. Phytic acid inhibits free radical formation in vitro but does not affect liver oxidant or antioxidant status in growing rats. J. Nutr. 128:1950-1955.
87. Owen, R.W., Spiegelhalder, B., and Bartsch, H. 1998. Phytate, reactive oxygen species and colorectal cancer. Eur. J. Cancer Prev. (Suppl) 2:S41-54.
88. Babbs, C.F. 1990. Free radicals and the etiology of colon cancer. Free Rad. Biol. Med. 8:191-200.
89. Erhardt, J.G., Lim, S.S., Bode, J.C., and Bode, C. 1997. A diet rich in fat and poor in dietary fiber increases the in vitro formation of reactive oxygen species in human feces. J. Nutr. 127:706-709.
90. Porres, J.M., Stahl, C.H., Cheng, W.H., Fu, Y., Roneker, K.R., Pond, W.G., and Lei, X.G. 1999. Dietary intrinsic phytate protects colon from lipid peroxidation in pigs with a moderately high dietary iron intake. Proc. Soc. Exp. Biol. Med. 221:80-86.
91. Menniti, F.S., Oliver, K.G., Putney, J.W. Jr., and Shears, S.B. 1993. Inositol phosphates and cell signaling: new views of InsP5 and InsP6. Trends Biochem. Sci. 18:53-56.
92. Berridge, M.J. and Irvine, R.F. 1989. Inositol phosphates and cell signalling. Nature (London) 341:197-205.
93. Davidson, L.A., Jiang, Y.H., Derr, J.N., Aukema, H.M., Lupton, J.R., and Chapkin, R.S.1994. Protein kinase C isoforms in human and rat colonic mucosa. Arch. Biochem. Biophys. 312:547-553.
94. Berridge, M.J. 1981. Phosphatidyl glycerol hydrolysis: a multifunctional transducing mechanism. Mol. Cell. Endocrinol. 24:115-140.
95. Vucenik. I., Tantivejkul, K., Anderson, L.M., and Ramljak, D. 2001. Inositol hexaphosphate may exert its antiproliferative effects by affecting the proteins involved in the regulation of the G1/S transition of the cell cycle (Abstract) J. Nutr. 131:193S.
96. Huang, C., Ma, W.Y., Hecht, S., and Dong, Z. 1997. Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidyl-inositol-3‘kinase. Cancer Res. 57:2873-2878.
97. Huang, C., Ma, W.Y., and Dong, Z. 1996. Requirement of phosphatidylinositol-3-kinase in epidermal growth factor induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol. 16:6427-6435.
98. Huang, C., Schmid, P.C., Ma, W.Y., and Schmid, H.H.O. 1997. Phosphatidylinositol-3-kinase is necessary for 12-0-tetradecanoylphorbol-13-acetate-induced cell transformation and AP-1 activation. J. Biol. Chem. 272:4187-4194.
99. Phillips, W.A., St. Clair, F., Munday, A.D., Thomas, R.I.S., and Mitchell, C.A. 1998. Increased levels of phosphatidyl-3-kinase activity in colorectal tumours. Cancer 83:41-47.
100. Wattenberg, L.W. and Estensen, R.D. 1996. Chemopreventive effects of myoinositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1(3-pyridyl)-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res. 56:5132-5135.
101. Chang, W.C.L., Chapkin, R.S., and Lupton, J.R. 1997. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumourigenesis. Carcinogenesis 18:721-730.
102. Baten, A., Ullah, A., Tomazic, V.J., and Shamsuddin, A.M. 1989. Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis 10:1595-1598.
103. Klevay, L.M. 1975. Coronary heart disease: the zinc/copper hypothesis. Amer. J. Clin. Nutr. 28:764-774.
104. Mathur, K.S., Singhal S.S., and Sharma R.D. 1964. Effect of Bengal gram on experimentally induced high levels of cholesterol in tissue and serum in albino rats. J. Nutr. 84:201-204.
105. Wolk, A., Manson, J.E., Stampfer, M.J., Colditz, G.A., Hu, F.B., Speizer, F.E., Hennekens, C.H., andWillett, W.C. 1999. Long term intake of dietary fiber and decreased risk of coronary heart disease among women. J. Amer. Med. Assoc. 281:1998-2004.
106. Vuksan, V., Jenkins, D.J., Vidgen, E., Ransom, T.P., Ng, M.K., Culhane, C.T., and O’Connor, D. 1999. A novel source of wheat fiber and protein: effects on fecal bulk and serum lipids. Amer. J. Clin. Nutr. 69:226-230.
107. Thompson, L.U. 1989. Nutritional and physiological effects of phytic acid, in Food Proteins, Kinsella, J.E. and Soucie, W.G., Eds,. American Oil Chemists Society, Champaign, IL, pp. 410-431.
108. Jenkins, D.J., Kendall, C.W., Vuksan, V., Augustin, L.S., Mehling, C., Parker, T., Vidgen, E., Lee, B., Faulkner, D., Seyler, H., Josse, R., Leiter, L.A., Connelly, P.W., and Fulgoni, V. 1999. Effect of wheat bran on serum lipids: influence of particle size and wheat protein. J. Amer. Coll. Nutr. 18:159-165.
109. Klevay, L.M. 1977. Elements of ischemic heart disease. Perspect Biol Med. 20:186-92.
110. Sharma, R.D. 1980. Effect of hydroxy acids on hypercholesterolaemia in rats. Atherosclerosis 37:463-468.
111. Jariwalla, R.J., Sabin, R., Lawson, S., and Herman, Z. 1990. Lowering of serum cholesterol and triglycerides and modulation of divalent cations by dietary phytate. J. Applied Nutr. 42:18-28.
112. Hiasa, Y., Kitahori, Y., Morimoto, J., Konishi, N., Nakaoka, S., and Nishioka, H. 1992. Carcinogenicity study in rats of phytic acid “daiichi”, a natural food additive. Food Chem. Toxicol. 30:117-125.
113. Rao, P.S., Liu, X., Das, D.K., Weinstein, G.S., and Tyras, D.H. 1991. Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant. Ann. Thorac. Surgery 52:908-912.
114. Seely, S. 1991. Is calcium excess in western diet a major cause of arterial disease? Int. J. Cardiol. 33:191-198.
115. Van den Berg, C.J., Hill L.F., and Stanbury S.W. 1972. Inositol phosphates and phytic acid as inhibitors of biological calcification in the rat. Clin. Sci. 43:377-383.
116. Thompson, L.U. 1993. Potential health benefits and problems associated with antinutrients in foods. Food Res. Intl. 26:131-149.
117. Deshpande, S.S. and Cheryan, M. 1984. Effects of phytic acid, divalent cations and their interactions on alpha-amylase activity. J. Food Sci. 49:516-519.
118. Thompson, L.U. and Yoon, J.H. 1984. Starch digestibility as affected by polyphenols and phytic acid. J. Food Sci. 49:1228-1229.
119. Katayama, T. 1995. Effect of dietary sodium phytate on the hepatic and serum levels of lipids and on the hepatic activities of NADPH-generating enzymes in rats fed on sucrose. Biosci. Biotechnol. Biochem. 59:1159-1160.
120. McKeown-Eyssen, G. 1994. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol. Biomarkers Prev. 3:687-695.
121. Giovannucci, E. 1995. Insulin and colon cancer. Cancer Causes Control 6:164-179.
122. Bruce, W.R. and Corpet, D.E. 1996. The colonic protein fermentation and insulin resistance hypothesis for colon cancer etiology: experimental tests using precursor lesions. Eur. J. Cancer Prev. 2:41-47.
123. Grases, F., Ramis, M., and Costa-Bauza, A. 2000. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization. Comparison with the action of other polyphosphates. Urol. Res. 28:136-140.
124. Grases, F., Garcia-Gonzalez, R., Torres, J.J., and Llobera, A. 1998. Effects of phytic acid on renal stone formation in rats. Scand. J. Urol. Nephrol. 32:261-265.
125. Grases, F., Prieto, R.M., Simonet, B.M., and March, J.G. 2000. Phytate prevents tissue calcifications in female rats. Biofactors 11:171-177.
126. Grases, F., March, J.G., Prieto, R.M., Simonet, B.M., Costa-Bauza, A., Garcia-Raja, A., and Conte, A. 2000. Urinary phytate in calcium oxalate stone formers and healthy people-dietary effects on phytate excretion. Scand. J. Urol. Nephrol. 34:162-164.
127. Ohkawa, T., Ebisuno, S., Kitagawa, M., Morimoto, S., Miyazaki, Y., and Yasukawa, S. 1984. Rice bran treatment for patients with hypercalciuric stones: experimental and clinical studies. J. Urol. 132:1140-1145.
128. Grases, F., Simonet, B.M., March, J.G., and Prieto, R.M. 2000. Inositol hexakisphosphate in urine: the relationship between oral intake and urinary excretion. Brit. J. Urol. Intl. 85:138-142.
129. Hirose, M., Fukushima, S., Imaida, K., Ito, N., and Shirai, T. 1999. Modifying effects of phytic acid and gamma-oryzanol on the promotion stage of rat carcinogenesis. Anticancer Res. 19:3665-3670.
130. Takaba, K., Hirose, M., Ogawa, K., Hakoi, K., and Fukushima, S. 1994. Modification of n-butyl-n(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in rats by phytic acid and its salts. Food Chem. Toxicol. 32:499-503.
131. Takaba, K., Hirose, M., Yoshida, Y., Kimura, J., Ito, N., and Shirai, T. 1997. Effects of n-tritriacontane-16,18-dione, curcumin, chlorphyllin, dihydroguaiaretic acid, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model. Cancer Lett. 113:39-46.